Micah Cost, Pharm.D., M.S.
Micah Cost, PharmD, MS, is Chief Executive Officer of Pharmacy Quality Alliance.
Articles
High-Impact Measurement for Chronic Conditions Helps Avoid Excess Care Costs
June 18th 2024Adherence measures developed by the Pharmacy Quality Alliance (PQA) are an important part of the Medicare Part D Star Ratings program. PQA has launched a Health Equity Technical Expert Panel to provide input on specific approaches to ensuring PQA’s measures support equitable health care.
Read More
Latest Updated Articles
Published: November 5th 2024 | Updated: November 21st 2024
The Mainstreaming of CAR-T
Published: November 18th 2024 | Updated: November 21st 2024
FDA Approves First-in-Class Drug for Rare Leukemia
Published: November 19th 2024 | Updated: November 21st 2024
Lung Association, Merck Partner to Raise Awareness of PAH
Published: May 8th 2024 | Updated: November 21st 2024
FDA Sets Date for Advisory Committee Meeting for Midomafetamine for PTSD
Published: June 5th 2024 | Updated: November 21st 2024
Updated: FDA Committee, Concerned about Bias, Votes No on Psychedelic in PTSD
Published: August 12th 2024 | Updated: November 21st 2024
FDA Issues Complete Response Letter for MDMA-Assisted Therapy for PTSD
